China leads in digital health and biotech, book argues

China runs more clinical trials than the U.S. and accounts for up to half of global drug licensing deals. Physician Ruby Wang's book China Cure examines the rise of Chinese biotech and AI medicine and urges the West to learn from it.

• China conducts more clinical trials than the U.S.
• China's share of global drug licensing deals reaches 50–60%
• BCI is named a 'future industry' in China's five-year plan
• Pfizer licensed drug candidates from 3SBio and Innovent